Pharmaceutical Transparency has arrived in Europe

Now that pharmaceutical companies have disclosed the amounts paid to Healthcare Professionals and Healthcare Organisations by pharmaceutical companies during 2015 in both USA and Europe, it should be very easy for Compliance Officers to spot trends and check whether or not their company is operating in line with others in the industry.  But is it really that simple?

We are conducting analysis and have already noticed several interesting features in the data.  The data must be looked at within the overall context and will need careful interpretation and insights before any conclusions can be drawn or decisions made.

If you would like a copy of our analysis, including our insights into what the data tell us about the industry and individual companies, or you would like us to conduct some specific analysis for you, please do contact us.

Comments are closed.

Linked in